Amrize stock: Jefferies cuts rating on margin risks
Published on 11/16/2026 at 17:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSJefferies Raises Margin Concerns
- Jefferies moved Amrize to Underperform from Hold in a November 16 analyst action.
- The firm cited volume, cost and residential-market pressure ahead of 2027.
- Amrize's savings program remains a key factor in the longer-term margin case.
Jefferies cut Amrize to Underperform from Hold on Monday, November 16, and lowered its price target to 35.20 US dollars from 42.80 US dollars. Investing.com reported that analyst Glynis Johnson pointed to difficult volume and cost comparisons in the first half of 2027.
Costs Test The 2027 Outlook
Jefferies expects higher raw-material, energy and freight costs through the second half of 2026 and into 2027 to weigh on Amrize margins. In Building Envelope, management sees positive price-cost development in 2027, while Jefferies expects the path to cost neutrality to extend into the summer of that year.
The firm also sees weaker residential demand limiting price realization in cement. That view adds pressure to the recovery case after Amrize's third-quarter results and recent guidance reset.
Savings Remain A Strategic Lever
Amrize targets savings equivalent to 50 basis points of margin per year through 2028. For investors, the timing of those savings and the company's ability to pass through input costs will be central to the earnings outlook. Jefferies said the investment case is becoming more dependent on mergers and acquisitions as operating conditions weaken.
Amrize stock traded at 36.87 euros on Lang & Schwarz at 16:45 CET on Monday, November 16.
Amrize Company Facts
- Company: Amrize Ltd
- ISIN: CH1430134226
- Ticker: AMRZ
- Trading venue: Lang & Schwarz
- Price: 36.87 euros on November 16, 2026 at 16:45 CET
Broader market context is available in Current market reports.
